📦 NDC / package directory — not a drug information page
Ravulizumab NDCs, Package Codes, Strengths & Labelers
This page lists NDC package records for Ravulizumab products — strengths, dosage forms, package sizes, labelers, 11-digit billing NDCs, pricing data when available, and links to each individual NDC page. It’s an NDC/package & billing directory, not a clinical drug page.
Key stats
6
Package NDCs
5
Products
5
Active listings
0
Discontinued
3
Labelers
5
Strengths
3
Dosage forms
0
With NADAC pricing
By strength, form & labeler
NDC products by strength
By dosage form
Top labelers
Browse records — 5 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| ravulizumab 10 mg/mL SOLUTION | 42098-0003-05 | — | On market | View → |
| ravulizumab 100 mg/mL INJECTION, SOLUTION | 61434-0076-00 | — | On market | View → |
| Ultomiris ravulizumab 300 mg/30mL SOLUTION, CONCENTRATE | 25682-0022-01 | — | On market | View → |
| Ultomiris ravulizumab 1100 mg/11mL SOLUTION, CONCENTRATE | 25682-0028-01 | — | On market | View → |
| Ultomiris ravulizumab 300 mg/3mL SOLUTION, CONCENTRATE | 25682-0025-01 | — | On market | View → |
Where does this data come from?
NDC package records, strengths, forms and labelers come from the openFDA NDC Directory; pricing is CMS NADAC. Grouped by active-ingredient name. This is package/billing reference data, not clinical drug information.